Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg / day) in a Q.I.D. regimen
Titel:
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg / day) in a Q.I.D. regimen
Auteur:
Chadwick, D.W Betts, T.A Boddie, H.G Crawford, P.M Lindstrom, P Newman, P.K Soryal, I Wroe, S Holdich, T.A.H